Year: 2026
Type: article
Source: JCO oncology advances.
DOI: 10.1200/oa-26-00033
Authors: Jabra Zarka, Daniel S. Roberson, Peter F. Rosen, Susanna Gregory, Joanina Gicobi, Lynn M. Flickinger, Olivia Bobek, Joshua C. Pritchett, Anthony Tabiim, Albert Jang, Abhinav Khanna, Elisabeth Heath, Lance Pagliaro, Daniel S. Childs, Brian A. Costello, Karla V. Ballman, Vidit Sharma, John C. Cheville, R. Jeffrey Karnes, Josep Domingo-Domenech, Stephen A. Boorjian, Aadel A. Chaudhuri, Fabrice Lucien, Paras Shah, Jacob J. Orme
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: U.S. Department of Defense, Cancer Research Institute, Prostate Cancer Foundation, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Gilead Sciences, American Society of Clinical Oncology, Wayne State University, Regeneron Pharmaceuticals, Exelixis, National Comprehensive Cancer Network, Five Prime Therapeutics, Mirati Therapeutics, Janssen Scientific Affairs, Barbara Ann Karmanos Cancer Institute, Calithera Biosciences, MacroGenics, Seagen, Daiichi-Sankyo, Eisai, Astellas Pharma, Genentech, EMD Serono, Pharmacyclics, National Cancer Institute, Janssen Biotech, Daiichi Sankyo Europe
OpenAlex ID: W7170058455